Medical Advocates
Pegylated Interferons
  Hepatitis C Treatment Adverse Events

General Adverse Events
 Cryoglobulinemia
 Fatigue
 Mental Disorders
 Digestive Disorders
 Neurological Disorders
 Ocular Disorders
 Sarcoidosis


 

  
Peg Interferons HCV Main Page Main New/Newsworthy Home Page

Last Update:  October 22, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Adverse Events  
     
     Peg Interferon/Ribavirin
 
  FULL TEXT PDF ARTICLE
 Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.
 Arase Y, Suzuki F, Suzuki Y, et al  
Intern Med. 2007;46(22):1827-32.
Paper
Cryoglobulinemia
     

     Peg Interferon alfa

          Journal Papers, Abstracts, and Commentaries
 
  Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment
of hepatitis C with peginterferon alfa.
 Batisse D, Karmochkine M, Jacquot C, et al
Eur J Gastroenterol Hepatol. 2004 Jul;16(7):701-3.
 Abstract
Fatigue
     
     Peg Interferon/Ribavirin
 
            Conference Reports, Abstracts, and Posters 
 
  High prevalence of fatigue and depression in HIV/Hepatitis C co-infected patients
treated with pegylated Interferon/Ribavirin
K L N Jones, S J Ferrando, A H Talal, et al
(15IAC)
 Abstract
Mental Disorders
     

     Peg Interferon/Ribavirin
 
            Conference Reports, Abstracts, and Posters 
 
  High prevalence of fatigue and depression in HIV/Hepatitis C co-infected patients
treated with pegylated Interferon/Ribavirin
K L N Jones, S J Ferrando, A H Talal, et al
 (I5IAC)
 Abstract

Digestive System Disorders
     

     Peg Interferon/Ribavirin

          Journal Papers, Abstracts, and Commentaries

  Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic
hepatitis C.
Leung Y, Urbanski SJ, Schindel L, Myers RP.
Can J Gastroenterol. 2006 Oct;20(10):661-3.
 Abstract
Neurological Disorders
     
          Journal Papers, Abstracts, and Commentaries
 
  Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients
with HCV.
 Briani C, Chemello L, Zara G, et al
 Neurology. 2006 Sep 12;67(5):781-5.
Abstract
Ocular Disorders
     

          Journal Papers, Abstracts, and Commentaries
 
 
UK prospective study of change in visual function in patients treated with Peginterferon alpha
for hepatitis C.
Malik NN, Sheth HG, Ackerman N, et al
 Br J Ophthalmol. 2007 Oct 25;
Abstract
 
Ocular complications of hepatitis C treatment
Sauer A, Lenoble P, Bader P, et al
J Fr Ophtalmol. 2007 Sep;30(7)
Abstract

Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin:
case report.
 Avila MP, Freitas AM, Isaac DL, et al
Arq Bras Oftalmol. 2006 Mar-Apr;69(2):255-9.
 Abstract
Sarcoidosis
     

     Peg Interferon alfa/Ribivirin

          Journal Papers, Abstracts, and Commentaries
 
 
Pulmonary sarcoidosis associated with pegylated interferon in the treatment of chronic
hepatitis C.
 Ubina-Aznar E, Fernandez-Moreno N, Rivera-Irigoin R, et al 
Gastroenterol Hepatol. 2005 Oct;28(8):450-2
 Abstract

Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic
hepatitis C: a case report and review of the literature.
 Hurst EA, Mauro T. 
Arch Dermatol. 2005 Jul;141(7):865-8.
Abstract

Peg Interferons HCV Main Page Main New/Newsworthy Home Page

Pegylated Interferons
Hepatitis C Treatment Adverse Events